GlassScriptPhysician profile
Srivani Sridhar
NPI 1003075318
$1,577.26
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $312 · 2022: $311 · 2023: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $364.77 | 2019-2022 | |
| Amgen INC. | $205.18 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.52 | 2019-2020 | |
| Amarin Pharma, INC. | $150.79 | 2019 | |
| Abbott Laboratories | $141.17 | 2020-2023 | Freestyle Libre 3 |
| Abbvie INC. | $125.00 | 2019 | |
| Dexcom, INC. | $124.99 | 2023 | Dexcom G7 Gss (161) |
| Janssen Pharmaceuticals, INC | $117.55 | 2019-2022 | |
| Glaxosmithkline, LLC. | $56.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.42 | 2019 | |
| Pfizer INC. | $31.02 | 2019 | |
| Novo Nordisk INC | $27.35 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.32 | 2019 | |
| Merck Sharp & Dohme LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srivani Sridhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.